Rare diseases and not-so-rare bureaucratic delays

Policy announced last year gave hope to patients, but its implementation is yet awaited

Manjit Singh | November 23, 2018


#National Policy on Treatment of Rare Diseases   #healthcare   #Rare diseases   #health ministry  


Ashan was all of only 21 months when he lost his battle to a rare genetic disorder on November 18. During his last days at the Lok Nayak Jai Prakash Narayan hospital in the capital, his distraught family left no stone unturned, and appealed to various authorities for facilitating right treatment as promised under the National Policy on Treatment of Rare Diseases. To no avail.

The disease was rare; the case is not. Patients are losing lives as the government is yet to finalise the modalities of implementing the policy. When it was announced last year, it was widely welcomed, but it is now over 78 weeks and patients are still awaiting action. More than 20 children have lost their lives in this period, 10 alone in Tamil Nadu.

The policy has been entangled in bureaucratic hold-up between the centre and states. There has been no headway in the implementation process despite the favourable judicial intervention in many states to initiate the treatment. A corpus of Rs 100 crore announced in the policy remained unused, and lapsed with the end of the last financial year. 

Some efforts have indeed been made: for example, setting up the central technical committee (CTC), state technical committees (STCs) and the rare disease cell for the application process to initiate treatment. But did the move make the process of getting treatment easier for patients? No.

The tedious and lengthy application process is only adding up to the complications. At first, the family of the patient has to apply to the rare disease cell directly or through a designated state health hospital. The application is forwarded to the STC by the hospital, which further forwards it to CTC after necessary reviews. The funds are then supposed to be released to the designated hospital under the PIP (60:40 ratio), only once the CTC approves it. It is only after this tiring and cumbersome procedure that the treatment can be initiated. Sadly, not even a single patient has been enrolled or approved for treatment in over 17 months.

The rare disease cell of the health ministry has received 180-odd applications, but there has been no headway. The centre is taking its own time to formulate guidelines to give it a structure for processing the applications and providing treatment.

For those trying to cope with the prohibitively expensive nature of treatment, untimely diagnosis, lack of insurance coverage and lack of state or social security, this is an ordeal they do not deserve to go through.

Over the last one decade, patient groups, medical professionals, social stakeholders and also the judiciary have been striving to ensure treatment for rare disease patients. In fact, there have been umpteen representations to the centre to get the rare disease policy in place. The need of the hour is to recognise rare diseases as a health priority and not dismiss them as diseases that affect only a “selected few”, thereby, following the promises and recommendations made in the policy.

Until and unless concrete measures are taken and adopted to improve patient outcomes, the policy’s purpose will be defeated. There is a dire need to set in motion, an immediate call-to-action for the implementation of the National Policy for Treatment of Rare Diseases. It is time for the centre, states and the stakeholders to come together to combat rare diseases.

Singh is president of Lysosomal Storage Disorder Support Society

Comments

 

Other News

Understanding Bharat’s history from its own perspective

Eminent Distorians: Twists and Truths in Bharat`s History By Utpal Kumar BluOne Ink, 334 pages

‘MAGA’ + ‘MIGA’ = ‘MEGA’ partnership for prosperity: Modi

Prime minister Narendra Modi has linked the dream of a Viksit Bharat with US president Donald Trump’s slogan, ‘Make America Great Again’, or ‘MAGA’, saying that when these two democracies work together, i.e. ‘MAGA’ plus ‘Make India Great Again’ (‘

ONOE: Anti-federalism or pro-reform?

The government`s move to implement ‘One Nation, One Election’ (ONOE) has ignited widespread debate. On one hand, it offers tangible benefits, such as removing the possibility of a governance paralysis and reducing election costs. On the other hand, the opposition and sections of civil society s

PM Surya Ghar: Muft Bijli Yojana completes first year

On February 13, 2025, the PM Surya Ghar: Muft Bijli Yojana (PMSGMBY) will mark its first anniversary, celebrating a year of empowering households with affordable solar energy and accelerating India’s transition to a sustainable future. Launched by prime minister Narendra Modi on Febru

How to leverage AI to solve urgent global issues

The world seems to be hurling towards World War III in all the possible scenarios: hot war, cold war, and proxy war. The battleground seems to have expanded beyond physical to digital or virtual/mixed reality with technology like drones. Moreover, the line between civilian and military targets seems to hav

Budget: Progress towards SDGs and areas for improvement

The Union Budget 2025-26 outlines India`s vision for economic and social growth while also reflecting the country`s commitment to sustainable development. As India moves closer to the 2030 deadline for the United Nations’ Sustainable Development Goals (SDGs), this budget presents a balanced approach

Visionary Talk: Amitabh Gupta, Pune Police Commissioner with Kailashnath Adhikari, MD, Governance Now



Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter